FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Justice Vanilla Scent Anti-bacterial Hand Sanitizer Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Flammable, keep away from fire or flame.
For external use only. Do not use in the eyes or apply over large areas of the body.
In case of deep or puncture wounds, animal bites, or serious burns, consult a doctor.
Use only as directed. Do not drink. If taken internally, it will produce serious gastric disturbances.
irritation persists for more than 72 hours.
Supervise children in the use of this product.
In case of deep or puncture wounds, animal bites, or serious burns, consult a doctor.
Stop use and ask a doctor ifirritation persists for more than 72 hours.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
- For hand washing to decrease bacteria on the skin.
- Recommended for repeated use.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Justice Vanilla Scent Anti-bacterial Hand Sanitizer Manufacturers
- Tween Brands Inc
- Tween Brands Inc
- Tween Brands Inc
Justice Vanilla Scent Anti-bacterial Hand Sanitizer | Novartis Pharmaceuticals Corporation
2.1 DosingENTRESTO is contraindicated with concomitant use of an angiotensin-converting enzyme (ACE) inhibitor. If switching from an ACE inhibitor to ENTRESTO allow a washout period of 36 hours between administration of the two drugs [see Contraindications (4) and Drug Interactions (7.1)].
The recommended starting dose of ENTRESTO is 49/51 mg twice-daily.
Double the dose of ENTRESTO after 2 to 4 weeks to the target maintenance dose of 97/103 mg twice daily, as tolerated by the patient.
2.2 Dose Adjustment for Patients Not Taking an ACE inhibitor or ARB or Previously Taking Low Doses of These AgentsA starting dose of 24/26 mg twice-daily is recommended for patients not currently taking an ACE inhibitor or an angiotensin II receptor blocker (ARB) and for patients previously taking low doses of these agents. Double the dose of ENTRESTO every 2 to 4 weeks to the target maintenance dose of 97/103 mg twice daily, as tolerated by the patient.
2.3 Dose Adjustment for Severe Renal ImpairmentA starting dose of 24/26 mg twice-daily is recommended for patients with severe renal impairment (eGFR <30 mL/min/1.73 m2). Double the dose of ENTRESTO every 2 to 4 weeks to the target maintenance dose of 97/103 mg twice daily, as tolerated by the patient.
No starting dose adjustment is needed for mild or moderate renal impairment.
2.4 Dose Adjustment for Hepatic ImpairmentA starting dose of 24/26 mg twice-daily is recommended for patients with moderate hepatic impairment (Child-Pugh B classification). Double the dose of ENTRESTO every 2 to 4 weeks to the target maintenance dose of 97/103 mg twice daily, as tolerated by the patient.
No starting dose adjustment is needed for mild hepatic impairment.
Use in patients with severe hepatic impairment is not recommended.
Login To Your Free Account